207 related articles for article (PubMed ID: 20084527)
21. The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk.
Kong SY; Takeuchi M; Hyogo H; McKeown-Eyssen G; Yamagishi S; Chayama K; O'Brien PJ; Ferrari P; Overvad K; Olsen A; Tjønneland A; Boutron-Ruault MC; Bastide N; Carbonnel F; Kühn T; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Vasilopoulou E; Masala G; Pala V; Santucci De Magistris M; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Jakszyn P; Sánchez MJ; Dorronsoro M; Gavrila D; Ardanaz E; Rutegård M; Nyström H; Wareham NJ; Khaw KT; Bradbury KE; Romieu I; Freisling H; Stavropoulou F; Gunter MJ; Cross AJ; Riboli E; Jenab M; Bruce WR
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1855-63. PubMed ID: 26404963
[TBL] [Abstract][Full Text] [Related]
22. A Novel Approach: Investigating the Intracellular Clearance Mechanism of Glyceraldehyde-Derived Advanced Glycation End-Products Using the Artificial Checkpoint Kinase 1 d270KD Mutant as a Substrate Model.
Takeda K; Sakai-Sakasai A; Kajinami K; Takeuchi M
Cells; 2023 Dec; 12(24):. PubMed ID: 38132156
[TBL] [Abstract][Full Text] [Related]
23. Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species.
Niiya Y; Abumiya T; Shichinohe H; Kuroda S; Kikuchi S; Ieko M; Yamagishi S; Takeuchi M; Sato T; Iwasaki Y
Brain Res; 2006 Sep; 1108(1):179-87. PubMed ID: 16872585
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.
Katagiri M; Shoji J; Inada N; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2018 Apr; 38(2):607-615. PubMed ID: 28299499
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH.
Takeuchi M; Sakasai-Sakai A; Takata T; Ueda T; Takino J; Tsutsumi M; Hyogo H; Yamagishi S
Med Hypotheses; 2015 May; 84(5):490-3. PubMed ID: 25697114
[TBL] [Abstract][Full Text] [Related]
26. The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review.
Sakasai-Sakai A; Takata T; Takino JI; Takeuchi M
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813302
[TBL] [Abstract][Full Text] [Related]
27. Intracellular Toxic Advanced Glycation End-Products in 1.4E7 Cell Line Induce Death with Reduction of Microtubule-Associated Protein 1 Light Chain 3 and p62.
Takata T; Sakasai-Sakai A; Takeuchi M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057513
[TBL] [Abstract][Full Text] [Related]
28. Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite.
Sakai-Sakasai A; Takeda K; Suzuki H; Takeuchi M
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397439
[TBL] [Abstract][Full Text] [Related]
29. Role of Glyceraldehyde-Derived AGEs and Mitochondria in Superoxide Production in Femoral Artery of OLETF Rat and Effects of Pravastatin.
Hori E; Kikuchi C; Nagami C; Kajikuri J; Itoh T; Takeuchi M; Matsunaga T
Biol Pharm Bull; 2017 Nov; 40(11):1903-1908. PubMed ID: 28835584
[TBL] [Abstract][Full Text] [Related]
30. Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells.
Senavirathna L; Ma C; Chen R; Pan S
Cells; 2021 Apr; 10(5):. PubMed ID: 33923186
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
Kikuchi C; Sakasai-Sakai A; Okimura R; Tanaka H; Takata T; Takeuchi M; Matsunaga T
Biol Pharm Bull; 2021; 44(10):1399-1402. PubMed ID: 34602548
[TBL] [Abstract][Full Text] [Related]
32. Detection and determination of glyceraldehyde-derived advanced glycation end product.
Usui T; Shimohira K; Watanabe H; Hayase F
Biofactors; 2004; 21(1-4):391-4. PubMed ID: 15630233
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.
Kimura Y; Hyogo H; Yamagishi S; Takeuchi M; Ishitobi T; Nabeshima Y; Arihiro K; Chayama K
J Gastroenterol; 2010 Jul; 45(7):750-7. PubMed ID: 20112031
[TBL] [Abstract][Full Text] [Related]
34. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma.
Takino J; Nagamine K; Hori T; Sakasai-Sakai A; Takeuchi M
World J Hepatol; 2015 Oct; 7(23):2459-69. PubMed ID: 26483867
[TBL] [Abstract][Full Text] [Related]
35. Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death.
Takata T; Sakasai-Sakai A; Takeuchi M
Diabetol Metab Syndr; 2020; 12():54. PubMed ID: 32684984
[TBL] [Abstract][Full Text] [Related]
36. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.
Dong Z; Iwata D; Kitaichi N; Takeuchi M; Sato M; Endo N; Iwabuchi K; Ando R; Fukuhara J; Kinoshita S; Lennikov A; Kitamura M; Mizuuchi K; Kanda A; Noda K; Namba K; Yamagishi S; Ohno S; Ishida S
J Leukoc Biol; 2014 Dec; 96(6):1077-85. PubMed ID: 25201803
[TBL] [Abstract][Full Text] [Related]
37. Methylglyoxal-derived hydroimidazolone-1 evokes inflammatory reactions in endothelial cells via an interaction with receptor for advanced glycation end products.
Ishibashi Y; Matsui T; Nakamura N; Sotokawauchi A; Higashimoto Y; Yamagishi SI
Diab Vasc Dis Res; 2017 Sep; 14(5):450-453. PubMed ID: 28631505
[TBL] [Abstract][Full Text] [Related]
38. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
Kume S; Kato S; Yamagishi S; Inagaki Y; Ueda S; Arima N; Okawa T; Kojiro M; Nagata K
J Bone Miner Res; 2005 Sep; 20(9):1647-58. PubMed ID: 16059636
[TBL] [Abstract][Full Text] [Related]
39. Glyceraldehyde-derived advanced glycation end-products having pyrrolopyridinium-based crosslinks.
Shigeta T; Sasamoto K; Yamamoto T
Biochem Biophys Rep; 2021 Jul; 26():100963. PubMed ID: 33748437
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells.
Nasu R; Furukawa A; Suzuki K; Takeuchi M; Koriyama Y
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
